JPS63241465A - Dna probe - Google Patents
Dna probeInfo
- Publication number
- JPS63241465A JPS63241465A JP7446987A JP7446987A JPS63241465A JP S63241465 A JPS63241465 A JP S63241465A JP 7446987 A JP7446987 A JP 7446987A JP 7446987 A JP7446987 A JP 7446987A JP S63241465 A JPS63241465 A JP S63241465A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- rna
- virus
- detected
- labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 title abstract description 10
- 239000012634 fragment Substances 0.000 claims abstract description 14
- 230000000295 complement effect Effects 0.000 claims abstract description 13
- 108020004414 DNA Proteins 0.000 claims description 64
- 239000003298 DNA probe Substances 0.000 claims description 16
- 102000053602 DNA Human genes 0.000 claims description 12
- 108020003215 DNA Probes Proteins 0.000 claims description 11
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 9
- 238000002372 labelling Methods 0.000 abstract description 18
- 241000700605 Viruses Species 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 7
- 244000005700 microbiome Species 0.000 abstract description 7
- 241000725303 Human immunodeficiency virus Species 0.000 abstract description 2
- 208000006454 hepatitis Diseases 0.000 abstract description 2
- 231100000283 hepatitis Toxicity 0.000 abstract description 2
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 239000002585 base Substances 0.000 description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- CZIHNRWJTSTCEX-UHFFFAOYSA-N 2 Acetylaminofluorene Chemical compound C1=CC=C2C3=CC=C(NC(=O)C)C=C3CC2=C1 CZIHNRWJTSTCEX-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 206010023927 Lassa fever Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- NFOMHWALMFWNAQ-UHFFFAOYSA-N N-acetoxy-2-acetamidofluorene Chemical compound C1=CC=C2C3=CC=C(N(C(C)=O)OC(=O)C)C=C3CC2=C1 NFOMHWALMFWNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000404000 Tanapox virus Species 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 241001536558 Yaba monkey tumor virus Species 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は、ウィルス、微生物、あるいは動植物細胞など
のDNAまたはRNAを検出もしくは定量するための試
薬、すなわちDNAプローブに関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a reagent, ie, a DNA probe, for detecting or quantifying DNA or RNA of viruses, microorganisms, or animal and plant cells.
〈従来の技術〉
本来、DNAあるいはRNAの塩基配列は、ウィルス種
および生物種に固有である。そして、そのDNAまたは
RNAは、それに相補なりNAまたはRNAと特異的に
二重鎖を形成、つまりハイブリッドする。この性質を利
用して近年DNAプローブが、DNAまたはRNAの検
出もしくは定量のための試薬として用いられるようにな
った。<Prior Art> Originally, the base sequence of DNA or RNA is unique to each virus species and biological species. Then, that DNA or RNA specifically forms a double strand, that is, hybridizes, with the complementary NA or RNA. Taking advantage of this property, DNA probes have recently come to be used as reagents for detecting or quantifying DNA or RNA.
従来DNAプローブは、検出しようとするウィルス、微
生物、あるいは動植物細胞由来のDNAまたはRNAと
相補なりNAを標識剤で標識することにより調製されて
いる。使用されるDNAとしては、ウィルス、微生物、
必るいは動植物由来のDNAそのもの、あるいはその全
部または一部をベクターに組込んでクローニングしたD
NA、ざらに合成によるDNAがある。多くの場合、1
000塩基対以上の二重鎖DNAであり、合成りNAは
100塩塁以下の単′f1′cある。Conventionally, DNA probes are prepared by labeling DNA complementary to DNA or RNA derived from a virus, microorganism, or animal or plant cell to be detected with a labeling agent. The DNA used includes viruses, microorganisms,
D that has been cloned by incorporating DNA itself derived from animals or plants, or all or part of it into a vector.
NA and DNA are synthesized from scratch. In many cases, 1
It is a double-stranded DNA with a length of 000 base pairs or more, and the synthetic DNA is a single-stranded DNA with a length of 100 base pairs or less.
一方、標識は一般に放射性同位元素が使用されるが、最
近ヒオチンーアヒジン結合を利用したM素15識が行な
われている。つまり、卵白中等に存在する分子量68,
000の塩基性蛋白質であるアヒジンと分子量244の
ビオチンは、親和定数−+o15M−1の強い親和性を
示ずことから、検出しようとするDNAまたはRNAに
相補なりNAをその相補性を阻害しにくい低分子量のビ
オチンで標識し、検出しようとするDNAまたはRNA
とハイブリッドさせた後に酵素−アビジン複合体とビオ
チン−アビジンを結合ゼしめることにより酵素標識を行
なうのである。さらに、抗原抗体反応を利用する標識も
行なわれている。つまり、ビオチン、フルオレセイン、
N−アセトキシ−2−アセチルアミノフルオレンなどの
ハプテンを結合したDNAに対する抗体を蛍光または酵
素などで標識し、検出しようとするDNAまたはRNA
と相補であり、前記ハプテンを結合したDNAと検出し
ようとするDNAまたはRNAをハイブリッドさせた後
に、この標識抗体を抗原抗体反応により結合せしめて目
的とするDNAまたはRNAを検出する方法である。On the other hand, radioactive isotopes are generally used as labels, but recently M elements have been identified using hyotine-ahidine bonds. In other words, the molecular weight of egg white, etc. is 68,
Since ahidin, a basic protein with a molecular weight of 000, and biotin with a molecular weight of 244 do not exhibit a strong affinity with an affinity constant of -+o15M-1, they are complementary to the DNA or RNA to be detected, and NA is unlikely to inhibit the complementarity. DNA or RNA to be detected by labeling with low molecular weight biotin
Enzyme labeling is performed by hybridizing the enzyme-avidin complex with biotin-avidin. Furthermore, labeling using antigen-antibody reactions has also been carried out. That is, biotin, fluorescein,
DNA or RNA to be detected by labeling an antibody against DNA bound with a hapten such as N-acetoxy-2-acetylaminofluorene with fluorescence or an enzyme.
This is a method of detecting the target DNA or RNA by hybridizing the hapten-bound DNA with the DNA or RNA to be detected, and then binding the labeled antibody through an antigen-antibody reaction.
〈発明が解決しようとする問題点〉
従来のDNAプローブは、合成り’ N A 、標識さ
れた二重、ff1DNAを結合した単鎖DNAあるいは
二重鎖DNAでおり、合成りNAを除いては通常100
0塩基対以上のDNAである。二重鎖のプローブを用い
る場合には、検出しようとするDNAまたはRNAとハ
イブリッドさせるにあたり、アルカリまたは熱により変
性させて単鎖にする必要がある。さらに1000塩基対
以上の長いDNAで必るのでハイブリッドするのに長時
間を要する。また、互いに相補な鎖が共存するためにプ
ローブ同志のハイブリッドが起こり、検出しようとする
DNAまたはRNAとのハイブリッド効率が低下する。<Problems to be Solved by the Invention> Conventional DNA probes are single-stranded DNA or double-stranded DNA bound to synthetic DNA, labeled double DNA, or ff1 DNA; Usually 100
It is DNA with 0 base pairs or more. When using a double-stranded probe, it is necessary to denature it with alkali or heat to make it a single strand before hybridizing it with the DNA or RNA to be detected. Furthermore, since this is necessary for long DNAs of 1000 base pairs or more, it takes a long time for hybridization to occur. Furthermore, hybridization between probes occurs due to the coexistence of mutually complementary strands, reducing the efficiency of hybridization with DNA or RNA to be detected.
一方、合成りNAの場合は上記のような欠点はないが、
DNA鎖が短いために標識効率が極めて低い。On the other hand, synthetic NA does not have the above disadvantages, but
Labeling efficiency is extremely low because the DNA strand is short.
本発明は、このような従来のDNAプローブの欠点を解
消し、ハイブリッドに要する時間が短く、ハイブリッド
効率の高い、しかも標識効率のよい、操作が簡便なりN
Aプローブを提供することを目的とする。The present invention eliminates the drawbacks of conventional DNA probes, and provides short time required for hybridization, high hybrid efficiency, high labeling efficiency, and simple operation.
The purpose is to provide A probe.
く問題点を解決するための手段〉 上記目的は、以下の本発明により達成される。Means to solve problems〉 The above object is achieved by the present invention as described below.
すなわち本発明は、検出しようとするDNAまたはRN
A中の異なる部位と相補な異種単1’!DNA断片の各
々が標識化された、複数の標識化異種DNA断片からな
るDNAプローブを提供するものである。That is, the present invention can detect DNA or RN.
A heterologous single 1' that is complementary to a different site in A! The present invention provides a DNA probe consisting of a plurality of labeled heterologous DNA fragments, each of which is labeled.
本発明の検出しようとするDNAまたはRNAは特に限
定されないが、具体的には肝炎(A型、B型)ウィルス
、AIDSウィルス(HIV−nl)AT Lウイ/L
、ス(HI V−I > 、へ/L、ペス(ヘルペスシ
ンプレックス、バリセラ、シースター)ウィルス、サイ
トメガロウィルス、麻疹ウィルス、風疹ウィルス、ポリ
オーマウィルス、パピローマウィルス、SV40ウィル
ス、コクサラキーウィルス、エコーウィルス、インフル
エンザウィルス、狂犬病ウィルス、黄熱病ウィルス、日
本脳炎ウィルス、マールブルグ病ウィルス、アデノウィ
ルス、デングウィルス、EBウィルス、マンブスウイル
ス、ワタシニアウイルス、パルボウイルス、コクサラキ
ーウィルス、ロタウィルス、タナポックスウィルス、ヤ
バウイルス、ラッサ熱ウィルス、タバコモザイクウィル
ス、マイコプラズマ、ツツガムシリケッチャ、Q熱すケ
ッチャ、発疹ヂフスリケッヂャ、クラミゾイアトラコー
マナイス、クラミディアプシタコシス、リン菌、破傷風
菌、黄色ブドウ球菌、レンサ球菌、結核菌、緑膿菌、炭
痘菌、肺炎球菌、サルモネラ菌、コレラ菌、チフス菌、
パラチフス菌、ボツリヌス菌、プルセラ菌、赤痢菌、腸
炎ビブリオ菌、ペスト菌、大腸菌、カンピロバクタ−、
カンジダ菌、トキソプラズマ、マラリア、梅毒、肺瘍細
胞、癌細胞などのウィルス、おるいは細菌、真菌、原生
動物などの微生物、動植物細胞由来のDNAまたはRN
Aであり、それが全塩基配列をとどめていても、断片で
あっても、また二重鎖であっても、単鎖でおってもかま
わない。The DNA or RNA to be detected by the present invention is not particularly limited, but specifically, hepatitis (type A, type B) virus, AIDS virus (HIV-nl) AT Lwi/L
, HIV-I > , H/L, pes (herpes simplex, varicella, seastar) virus, cytomegalovirus, measles virus, rubella virus, polyoma virus, papilloma virus, SV40 virus, coxalaki virus, Echovirus, influenza virus, rabies virus, yellow fever virus, Japanese encephalitis virus, Marburg virus, adenovirus, dengue virus, EB virus, mambus virus, cotton sinia virus, parvovirus, coxalaki virus, rotavirus, tanapox Viruses, Yaba virus, Lassa fever virus, tobacco mosaic virus, mycoplasma, Tsutsugamushirikedcha, Q-heating Kecha, rash, Chlamyzoia trachomanis, Chlamydia apsittacosis, Phosphorus bacteria, Clostridium tetani, Staphylococcus aureus, Streptococcus , Mycobacterium tuberculosis, Pseudomonas aeruginosa, Bacillus anthracis, Streptococcus pneumoniae, Salmonella enterica, Vibrio cholerae, Salmonella typhi,
Salmonella paratyphi, Clostridium botulinum, Purcella, Shigella, Vibrio parahaemolyticus, Yersinia pestis, Escherichia coli, Campylobacter,
DNA or RNA derived from viruses such as Candida, toxoplasma, malaria, syphilis, lung cancer cells, cancer cells, microorganisms such as bacteria, fungi, and protozoa, and animal and plant cells.
A, and it does not matter whether it has the entire base sequence, a fragment, a double strand, or a single strand.
本発明によるDNAプローブは、ハイブリッド効率と標
識効率の高いことが特徴であり、検出しようとするDN
AまたはRNAの塩基配列に対し、個々の断片が総合的
に可能な限り広範囲に相補性を備えていることが望まし
く、最も望ましくは検出しにうとするDNAまたはRN
Aの全[J配列に対し連続的に相補性を備えていること
であるが、少なくとも1000塩塁以上の一領域あるい
は多領域であってもよく、その中で各断片か連続的に相
補でおっても断続的に相補であってもかまわない。従っ
て断片の数は多いほど好ましく、プローブの長さにもよ
るが、3個以上、ざらに好ましくは5個以上である。ま
た、−断片の大きさは100〜500塩基程度が好まし
く、150〜300塩基程度がさらに好ましい。The DNA probe according to the present invention is characterized by high hybridization efficiency and high labeling efficiency, and is characterized by high hybridization efficiency and high labeling efficiency.
It is desirable that the individual fragments comprehensively have as wide a range of complementarity as possible to the base sequence of A or RNA, and most preferably the DNA or RNA that is to be detected.
It must be continuously complementary to the entire [J sequence of A, but it may be one region or multiple regions of at least 1000 salt bases, within which each fragment is continuously complementary. It does not matter if they are intermittent or complementary. Therefore, the number of fragments is preferably as large as possible, and although it depends on the length of the probe, it is 3 or more, more preferably 5 or more. Furthermore, the size of the -fragment is preferably about 100 to 500 bases, more preferably about 150 to 300 bases.
本発明の単鎖DNAの調製法は特に限定しないが、例え
ばバタテリオファージM13のベクターなどでクローニ
ングした単鎖DNAを超音波で切断する方法、おるいは
その単鎖DNAを鋳型として複数のプライマーを酵素に
より伸長した後、鋳型DNAと分離する方法(特願昭6
2−30/120)等により調製することができる。The method for preparing the single-stranded DNA of the present invention is not particularly limited, but includes, for example, a method of cleaving single-stranded DNA cloned with a batatteriophage M13 vector using ultrasound, or using the single-stranded DNA as a template and using multiple primers. A method in which the DNA is elongated with an enzyme and then separated from the template DNA (patent application 1986).
2-30/120), etc.
このようにして得られた単鎖DNAは、通常の方法で標
識化することができる。すなわち、放射性同位元素、蛍
光物質、化学発光物質または酵素等の標識剤により直接
e、識しても良く、またビオチン、N−アセトキシ−2
−アセチルアミノフルオレン等の低分子物質を結合して
おき、これら低分子物質をハプテンとする抗体、あるい
はアヒジンなどの物質と標識剤との複合体で標識しても
良い。具体的には、たとえば単鎖DNAをフtトビオヂ
ン(バイオテクノロジー・リサーチ・エンタープライシ
ス社)おるいはケミプローブ(オルゲニクス社)等で処
理するか、またはDNA伸長の際に基質として3ト1.
32P必るいは125■などのラジオアイソトープ、ま
たはハプテン等を結合した塩基を用いる等の方法により
容易に標識化することができる。The single-stranded DNA thus obtained can be labeled using a conventional method. That is, it may be directly recognized by a labeling agent such as a radioactive isotope, a fluorescent substance, a chemiluminescent substance, or an enzyme, or it may be recognized by biotin, N-acetoxy-2
- A low-molecular substance such as acetylaminofluorene may be bound and labeled with an antibody using such a low-molecular substance as a hapten, or a complex of a substance such as ahidin and a labeling agent. Specifically, for example, single-stranded DNA is treated with Futobiodin (Biotechnology Research Enterprises) or Chemiprobe (Orgenics), or 3-stranded DNA is used as a substrate during DNA elongation.
Labeling can be easily carried out by methods such as using a radioisotope such as 32P or 125■, or a base bound to a hapten or the like.
本発明のDNAプローブを用い、ウィルス、微生物、動
植物細胞のDNAまたはRNAを検出するには、たとえ
ば次の方法により行なう。まずウィルスあるいは微生物
が存在すると思われる組織、または体液等の検体、もし
くは動植物細胞、癌細胞等をガラス板上に固定させる。The DNA or RNA of viruses, microorganisms, animal and plant cells can be detected using the DNA probe of the present invention, for example, by the following method. First, a sample such as tissue or body fluid in which viruses or microorganisms are thought to exist, animal or plant cells, cancer cells, etc. is fixed on a glass plate.
あるいは組織、体液、細胞より抽出したDNAまたはR
NAをニトロセルロース、ナイロン等の;濾過膜に固定
させる。次に検出しようとするDNAまたはRNAを変
性して単鎖にする。これを本発明のDNAプローブと共
にインキュベートすることにより、検出しようとするD
NAまたはRNAと、DNAプローブをハイブリッドさ
せる。予め、標識剤が結合していない場合は、ハイブリ
ッドしたDNAプローブを酵素などで標識し、基質によ
る標識酵素の発色等により検出する。なお、それぞれの
工程においては洗浄工程を経るのが通常である。Or DNA or R extracted from tissues, body fluids, or cells.
NA is immobilized on a filtration membrane such as nitrocellulose or nylon. Next, the DNA or RNA to be detected is denatured to become a single strand. By incubating this with the DNA probe of the present invention, the D.
Hybridize the DNA probe with NA or RNA. If no labeling agent has been bound in advance, the hybridized DNA probe is labeled with an enzyme or the like, and detected by color development of the labeled enzyme with a substrate. Note that each step usually includes a cleaning step.
また、電気泳動を利用した方法(特願昭61−9787
7>により検出することもできる。この方法は、変性し
た検出しようとするDNAまたはRNAの溶液に本発明
のDNAプローブを加えハイブリッドさせた後、厚さ2
〜3#のアガロース、ポリアクリルアミド等のゲル層面
に垂直に電気泳動させ、DNAプローブとハイブリッド
した検出しようとするDNAまたはRNAをグル1ff
i−ト必るいは内部に留め、ハイブリッドしなかったD
NAプローブはゲル層を通過させて除去することにより
、ゲル層上あるいは内部に留まったDNAプローブを検
出する方法である。In addition, a method using electrophoresis (patent application No. 61-9787)
7> can also be detected. In this method, the DNA probe of the present invention is added to a solution of denatured DNA or RNA to be detected, hybridized, and then a
Electrophoresis is performed perpendicularly to the surface of a gel layer of ~3# agarose, polyacrylamide, etc., and the DNA or RNA to be detected that has hybridized with the DNA probe is isolated with 1ff.
i-t must be kept inside or not hybridized D
The NA probe is a method of detecting DNA probes remaining on or inside the gel layer by passing through the gel layer and removing it.
く実 施 例〉 以下、実施例により本発明をざらに詳細に説明する。Example of implementation EXAMPLES Hereinafter, the present invention will be roughly explained in detail with reference to Examples.
実施例1
(1)肝炎B型ウィルス(HBv)DNAを組込んだM
13rnp19単鎖DNA (トIB/M13)の調製
”M13ファージによるクローニングとDide。Example 1 (1) M incorporating hepatitis B virus (HBv) DNA
"Preparation of 13rnp19 single-stranded DNA (IB/M13)" Cloning with M13 phage and Dide.
xyシークエンス法″(アマシVムジャパン株式会社1
984年1月1日発行)に従い、HB Vの制限酵素、
BamHIにより1.4Kbの断片を組込んだHB/M
13を得た。xy sequence method” (Amashi Vmu Japan Co., Ltd. 1)
HBV restriction enzyme,
HB/M with 1.4 Kb fragment incorporated by BamHI
I got 13.
(2)トIB/M13の切断開環
トIB/M13DNAのM13rnp19DNA塩基配
列中のクローニングIナイトの制限酵素トfind■認
識部位を含む塩基配列AAGCTTGCATGCCTG
と相補なりNAオリゴ?−(260μmで50.[)、
/ml> 15μgと、Ha/M13 (0゜5μ9/
μg>100μgを混合して55°Cで5分間、ざ、ら
に至温で5分間インキュベートしたLMgCfJ2を7
m)l、NaCFを60mMとなるように加え、t−1
ind I[I (10units /ufJ ) 8
μgを加えて37℃で3時間インキュベートした。電
気泳動により切断を確認した。(2) Cleavage of IB/M13 Cloning of IB/M13 DNA in the M13rnp19 DNA base sequence Restriction enzyme of I night Find ■ Base sequence containing recognition site AAGCTTGCATGCCTG
Complementary NA oligo? -(50.[) at 260 μm,
/ml> 15μg and Ha/M13 (0°5μ9/
LMgCfJ2, which was mixed with >100 μg and incubated at 55°C for 5 minutes and then at subtemperature for 5 minutes, was
m) l, add NaCF to 60mM, t-1
ind I [I (10 units /ufJ) 8
μg was added and incubated at 37° C. for 3 hours. Cleavage was confirmed by electrophoresis.
(3)伸 長
Ha/M13中のトIBV山来DNAのt−1indl
IIによる切断末端から約200塩基の間隔でその塩基
配列に相補な15塩基のDNAオリゴマーGCGGCT
AGGAGTTCF、CCTGTTTAGCTTGTA
、ATGTAGCCCATGAAG、AATGGCAC
TAGTAAA、TGG△ATTAGAGGACA、T
TGAGAG△△GTCCAC(260μmで各50.
0. /d )のそれぞれ15μgを(2)で得られた
切断開環HB/M13の溶液と混合して55°Cで5分
間、室温で5分間インキュベート後、各1mMのdAT
P、dCTP、dGTP、dTTPを含む緩衝液(67
…■リン酸カリウム、6.7mMM9CN 2、DI+
=7. /l ) 100μgと、5−アミノアリール
−dUTP(P。(3) t-1indl of ToIBV Yamaki DNA in elongated Ha/M13
A 15-base DNA oligomer GCGGCT complementary to the base sequence at an interval of about 200 bases from the cut end by II.
AGGAGTTCF, CCTGTTTAGCTTGTA
, ATGTAGCCCATGAAG, AATGGCAC
TAGTAAA, TGG△ATTAGAGGACA, T
TGAGAG△△GTCCAC (each 50.
0. /d) was mixed with the solution of cleaved ring-opened HB/M13 obtained in (2) and incubated at 55°C for 5 minutes and at room temperature for 5 minutes.
Buffer solution containing P, dCTP, dGTP, dTTP (67
...■ Potassium phosphate, 6.7mM9CN2, DI+
=7. /l) 100 μg and 5-aminoaryl-dUTP (P.
R,tangerら、 Proc、 Natl、
八cad、 Sei、 USA、 78゜663
3 (1981) ニ従い合成した〕の1.8mM水溶
液10μg1ざらにDNAポリメラーゼラージフラグメ
ント(4,2UnitS/VIG )3μ、11を加え
て25°Cで5分間インキュベートした。250m)!
EDTA水溶液(pH=7.0)50μgを加えて、)
1olccular Cloning (Cold S
pring Harbor Laboratory 1
982)に従い、フェノール抽出、エタノール沈澱によ
りDNAを回収した。R,tanger et al., Proc. Natl.
8cad, Sei, USA, 78°663
3 (1981)] was added to 10 μg of a 1.8 mM aqueous solution of DNA Polymerase Large Fragment (4,2 Unit S/VIG) 11, and incubated at 25° C. for 5 minutes. 250m)!
Add 50 μg of EDTA aqueous solution (pH = 7.0)
1olccular Cloning (Cold S
pring Harbor Laboratory 1
DNA was recovered by phenol extraction and ethanol precipitation according to 982).
(4) 伸長DNAの分離回収
3%agaroseのゲル膜(17ざ2 mm >の両
面にレルロース半透膜により仕切られた小室を設け、一
方に(3)で得られたDNAの溶液(50m)INAO
Hllmt(EDTA)を、他方に電気泳動溶液(30
mH1N a OHll mHE D T−A >を満
たし、電気泳動溶液中でDNA溶液側を陰極として電気
泳動(70Vで20分間)を行ない、陽極側小室より伸
長DNA溶液を得た。電気泳動でマーカーにより200
塩基のDNA1″′必ることを確認した。(4) Separation and recovery of elongated DNA A 3% agarose gel membrane (17 mm x 2 mm) was provided with small chambers partitioned by semipermeable membranes on both sides, and the DNA solution obtained in (3) was placed on one side (50 m). INAO
Hllmt (EDTA) on the other hand and electrophoresis solution (30
mH1N a OHll mHE D T-A > was filled, electrophoresis was performed in the electrophoresis solution (70 V for 20 minutes) with the DNA solution side as the cathode, and an elongated DNA solution was obtained from the small chamber on the anode side. 200 by marker by electrophoresis
It was confirmed that the base of the DNA was 1'''.
(5)ビオチン標識
得られたDNA溶液を0.1HNaHCO3水溶液中で
透析した。)層線して全組を900μρとし、Biot
in−X−NH3(Behring Diagnost
ics La Jotla、 CA92037)10t
l’j/ufJ DMF25μgを加えて室温で1時間
撹拌した。反応液をTE緩衝液(10m)l Tris
−tllll、1mME D l−A 、 l)l+
= 8 。(5) Biotin labeling The obtained DNA solution was dialyzed in a 0.1H NaHCO3 aqueous solution. ) Layer line and set the total set to 900μρ, Biot
in-X-NH3 (Behring Diagnost
ics La Jotla, CA92037) 10t
25 μg of l'j/ufJ DMF was added and stirred at room temperature for 1 hour. The reaction solution was diluted with TE buffer (10ml) Tris.
-tllll, 1mMED l-A, l)l+
= 8.
O)中で透析し、ビオチン標識DNAを冑た。The biotin-labeled DNA was removed by dialysis in O.
〈発明の効果〉
本発明によるDNAプローブは、ハイブリッドに要する
時間が短く、ハイブリッド効率も高く、しかも標識効率
がよいという優れたプローブである。さらに、単鎖でお
るため変性する必要かなく、使用するにあたり操作が簡
便でおるという利点がある。<Effects of the Invention> The DNA probe according to the present invention is an excellent probe in that the time required for hybridization is short, the hybridization efficiency is high, and the labeling efficiency is high. Furthermore, since it is a single chain, it does not need to be denatured and has the advantage of being easy to use.
Claims (1)
部位と相補な異種単鎖DNA断片の各々が標識化された
、複数の標識化異種DNA断片からなるDNAプローブ
。(1) A DNA probe consisting of a plurality of labeled heterologous DNA fragments, in which each heterologous single-stranded DNA fragment complementary to a different site in the DNA or RNA to be detected is labeled.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7446987A JPS63241465A (en) | 1987-03-30 | 1987-03-30 | Dna probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7446987A JPS63241465A (en) | 1987-03-30 | 1987-03-30 | Dna probe |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63241465A true JPS63241465A (en) | 1988-10-06 |
Family
ID=13548144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7446987A Pending JPS63241465A (en) | 1987-03-30 | 1987-03-30 | Dna probe |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63241465A (en) |
-
1987
- 1987-03-30 JP JP7446987A patent/JPS63241465A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3421664B2 (en) | Nucleotide base identification method | |
EP0235726B1 (en) | Rapid detection of nucleic acid sequences in a sample by labeling the sample | |
US5935825A (en) | Process and reagent for amplifying nucleic acid sequences | |
US5348855A (en) | Assay for nucleic acid sequences in an unpurified sample | |
CA2122450C (en) | Solid phase amplification process | |
EP2398915B1 (en) | Synthesis of sequence-verified nucleic acids | |
EP0281927B1 (en) | Assay for nucleic acid sequences in a sample | |
CA2157968C (en) | Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same | |
US8735067B2 (en) | Asymmetric PCR amplification, its special primer and application | |
WO2019209946A1 (en) | Sequential paired-end sequencing | |
JP7058502B2 (en) | Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications | |
JPH04502862A (en) | Method for rapidly detecting and/or identifying a single base on a nucleic acid sequence and its application | |
JPH06209775A (en) | Temperature sensitive polymerase inhibitor, thermostable dna polymerase composition containing said inhibitor and method for amplification of target nucleic acid | |
EP3098324A1 (en) | Compositions and methods for preparing sequencing libraries | |
EA005577B1 (en) | A material having an immobilized nucleic acid prepared by the method using a chimeric oligonucleotide primer, a dna polymerase and an endonuclease | |
JPH102898A (en) | Method for selectively preparing leucocyte and polymerase chain reaction kit | |
JP4047395B2 (en) | Method for simultaneous amplification of nucleic acids | |
JPH09289900A (en) | Amplifier of nucleic acid of cytomegalovirus (cmv) utilizing nucleic sequence (beta 2.7) and reagent kit for detection | |
JPH08501220A (en) | Isolated nucleotide sequence for identification of Neisseria gonorrhoeae | |
US20030013671A1 (en) | Genomic DNA library | |
Pettersson et al. | Nucleic acid hybridization—an alternative tool in diagnostic microbiology | |
JPS62265999A (en) | Detection of bacteria in nucleic acid-containing specimen | |
JPS63241465A (en) | Dna probe | |
JP2002520073A (en) | Vector storage | |
JP2008072951A (en) | Method for rapid detection of serum type of salmonella o4 group using lamp method |